Endurant Capital Management LP Axogen, Inc. Transaction History

Endurant Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$11.5 - $17.96 $807,403 - $1.26 Million	-70,209 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.62 - $13.12 $745,619 - $921,142	70,209 New	70,209 $817,000
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $584,229 - $884,336	-39,961 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $186,058 - $416,427	10,887 Added 37.45%	39,961 $816,000
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $989,969 - $1.63 Million	29,074 New	29,074 $1.07 Million

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.